| 产品名称： | FIGR |
|---|---|
| 商品货号： | TS212151 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with the glucorticoid receptor (GR) of mouse and rat, but does not react with human GR. The antibody produced by FIGR appears to be equivalent to that produced by the BUGR2 hybridoma in that the two antibodies will cross inhibit, and both bind to the same 16000 dalton tryptic fragment of GR. The antibody is useful for immunopurification and Western blotting applications. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | Spleen cells were fused with NS-1 myeloma cells. The antibody produced by FIGR appears to be equivalent to that produced by the BUGR2 hybridoma in that the two antibodies will cross inhibit, and both bind to the same 16000 dalton tryptic fragment of GR. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against glucocorticoid receptor of mouse and rat |
| Cellular Products： | immunoglobulin; monoclonal antibody; against glucocorticoid receptor of mouse and rat |
| Tumorigenic： | Yes |
| Effects： | Yes, in BALB/c mice |
| Comments： | Spleen cells were fused with NS-1 myeloma cells. |
| Complete Growth Medium： | Dulbeccos modified Eagles medium with 4.5 g/L glucose, 90%; iron supplemented bovine calf serum, 10%
|
| Subculturing： | Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 x 105 cells/mL and maintain between 1 x 105 and 1 x 106 cells/mL. Medium Renewal: Two to three times weekly. |
| Cryopreservation： | Complete growth medium described above supplemented with 5% (v/v) DMSO.xa0 Cell culture tested DMSO is available as ATCC Catalog No. 4-X. |
| Culture Conditions： | Temperature: 37°C
Atmosphere: Air, 95%; Carbon dioxide (CO2), 5% |
| Isotype： | IgG2b |
| Name of Depositor： | JE Bodwell |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Bodwell JE, et al. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J. Biol. Chem. 266: 7549-7555, 1991. PubMed: 2019585 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | FIGR |
|---|---|
| 商品货号： | TS212151 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with the glucorticoid receptor (GR) of mouse and rat, but does not react with human GR. The antibody produced by FIGR appears to be equivalent to that produced by the BUGR2 hybridoma in that the two antibodies will cross inhibit, and both bind to the same 16000 dalton tryptic fragment of GR. The antibody is useful for immunopurification and Western blotting applications. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | Spleen cells were fused with NS-1 myeloma cells. The antibody produced by FIGR appears to be equivalent to that produced by the BUGR2 hybridoma in that the two antibodies will cross inhibit, and both bind to the same 16000 dalton tryptic fragment of GR. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against glucocorticoid receptor of mouse and rat |
| Cellular Products： | immunoglobulin; monoclonal antibody; against glucocorticoid receptor of mouse and rat |
| Tumorigenic： | Yes |
| Effects： | Yes, in BALB/c mice |
| Comments： | Spleen cells were fused with NS-1 myeloma cells. |
| Complete Growth Medium： | Dulbeccos modified Eagles medium with 4.5 g/L glucose, 90%; iron supplemented bovine calf serum, 10%
|
| Subculturing： | Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 x 105 cells/mL and maintain between 1 x 105 and 1 x 106 cells/mL. Medium Renewal: Two to three times weekly. |
| Cryopreservation： | Complete growth medium described above supplemented with 5% (v/v) DMSO.xa0 Cell culture tested DMSO is available as ATCC Catalog No. 4-X. |
| Culture Conditions： | Temperature: 37°C
Atmosphere: Air, 95%; Carbon dioxide (CO2), 5% |
| Isotype： | IgG2b |
| Name of Depositor： | JE Bodwell |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Bodwell JE, et al. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J. Biol. Chem. 266: 7549-7555, 1991. PubMed: 2019585 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. |
